tfr 1

Anti-Mouse/Rat CD71/TfR1 Antibody (OX-26) is a mouse monoclonal inhibitory antibody that specifically recognizes the CD71/TfR1 target in mice and rats. It targets the transferrin receptor and specifically binds to its extracellular domain. It has been used in drug delivery research, especially in the field of brain-targeted drug delivery.

Anti-Mouse CD71/TfR1 Antibody (R17 217.1.3) is a rat-derived inhibitory antibody targeting mouse CD71/TfR1. It can deplete CD71-positive cells and inhibit the transferrin receptor, and is applicable to research on tumors, infections, inflammation, and immunology, including lung cancer, lymphocytic choriomeningitis virus infection, and heart transplantation.

Anti-Mouse CD71/TfR1 Antibody (8D3) is a rat-derived inhibitory antibody targeting mouse CD71/TfR1. It depletes CD71-positive erythroid cells without significantly affecting the proportion of regulatory T cells in neonatal mice, while enhancing the anti-infective ability of neonatal mice.

TfR-1-IN-1 is a transferrin receptor 1 (TfR-1) inhibitor, also an Fe(III) salivary phenol complex, with anticancer activity. It induces apoptosis, inhibits the growth of tumor cells and normal cells, and is used in studies of leukemia.

Anti-CD71/TfR1 Antibody (Jr-141 Naked Antibody) is a sophisticated humanized monoclonal antibody target the human transferrin receptor 1 (TfR1/CD71) with a measured dissociation constant (Kd) of 1.12 nM, functioning as the foundational component of the J-Brain Cargo technology for research involving receptor-mediated transcytosis across the blood-brain barrier.

HAIYPRH hydrochloride is a targeting ligand that specifically binds to the transferrin receptor (TfR) and facilitates the transport of nanocarriers across the blood-brain barrier [1].

TfR-T12 TFA, a transferrin receptor (TfR)-binding peptide capable of crossing the blood-brain barrier (BBB), exhibits nanomolar (nM) binding affinity [1] [2].